Precision BioSciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | 68.0% | 58.3% | 30.5% | 21.5% | 25.9% | 12.1% | 15.5% | 22.1% | 8.1% | 2.8% | 175.5% | 118.7% | – | 3,866.7% | 5,184.6% | 2.0% | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 32.0% | 41.7% | 69.5% | 78.5% | 74.1% | 87.9% | 84.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| 444.6% | 531.2% | 580.0% | 383.2% | 332.0% | 365.5% | 422.3% | 406.8% | 305.2% | 355.5% | 2,336.1% | 337.8% | 261.4% | 156.5% | 54.1% | 107.9% | 417.6% | 552.3% | 557.7% | 145.6% | 110.3% | 113.7% | 61.1% | 113.2% | 190.2% | 75.9% | 34.5% | 2,271.5% | 2,493.3% | 46,855.2% | 70,933.3% | 102,707.7% | 42.3% | 121.0% | – | 118.3% | |
| 147.4% | 173.2% | 167.0% | 127.9% | 94.0% | 91.5% | 120.6% | 145.0% | 130.0% | 137.4% | 807.3% | 115.9% | 104.0% | 58.1% | 14.4% | 40.1% | 167.5% | 322.3% | 274.5% | 140.4% | 95.0% | 126.3% | 49.7% | 73.4% | 121.3% | 47.9% | 17.1% | 1,522.0% | 1,501.1% | 29,493.1% | 50,705.6% | 56,369.2% | 21.1% | 62.8% | – | 62.4% | |
| 591.9% | 704.4% | 747.0% | 511.1% | 426.0% | 456.9% | 543.0% | 551.8% | 435.2% | 492.9% | 3,143.4% | 453.7% | 365.4% | 214.6% | 68.6% | 148.0% | 585.1% | 856.4% | 816.6% | 268.8% | 192.8% | 226.2% | 103.8% | 178.7% | 311.6% | 123.8% | 51.6% | 3,793.6% | 3,994.4% | 76,348.3% | 121,638.9% | 159,076.9% | 63.4% | 183.7% | – | 180.8% | |
| -491.9% | -604.4% | -647.0% | -411.1% | -326.0% | -356.9% | -443.0% | -451.8% | -335.2% | -392.9% | -3,043.4% | -353.7% | -265.4% | -114.6% | 31.4% | -48.0% | -485.1% | -824.4% | -774.9% | -199.3% | -114.3% | -152.1% | -15.8% | -94.2% | -211.6% | -23.8% | 48.4% | -3,693.6% | -3,894.4% | -76,248.3% | -121,538.9% | -158,976.9% | 36.6% | -83.7% | – | -80.8% | |
| 11.9% | 11.9% | 9.7% | – | 3.7% | 3.3% | 0.0% | 0.0% | 5.6% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.2% | 0.8% | 1.3% | 4.7% | 5.5% | 4.6% | 5.9% | 2.8% | 4.4% | 8.2% | 3.3% | 1.1% | 44.4% | 61.4% | 1,220.7% | 1,988.9% | 2,784.6% | 1.0% | 2.9% | – | 2.9% | |
| -484.4% | -589.8% | -631.1% | -383.9% | -312.6% | -581.9% | -360.7% | -426.4% | -320.7% | -383.5% | -3,033.5% | -353.3% | -265.1% | -114.3% | 31.5% | -46.9% | -351.6% | -849.2% | -812.4% | -213.1% | -183.3% | -158.9% | -15.3% | -92.3% | -190.9% | 48.8% | 65.6% | -2,851.6% | -2,781.3% | -70,913.8% | -130,666.7% | -167,476.9% | 56.3% | -170.2% | – | -119.0% | |
| 0.0% | 14.6% | 16.0% | 27.2% | -24.6% | -229.3% | 54.7% | 25.4% | 14.5% | 9.4% | 9.9% | 0.4% | 0.3% | – | 0.1% | 0.2% | 0.8% | 24.8% | 37.5% | 13.8% | 75.5% | -17.1% | -16.2% | -40.6% | 40.6% | 7.9% | -2.8% | 666.5% | -0.3% | – | – | – | – | – | – | – | |
| -484.4% | -589.8% | -631.1% | -383.9% | -312.6% | -581.9% | -360.7% | -426.4% | -320.7% | -383.5% | -3,033.5% | -353.3% | -265.1% | -114.3% | 31.5% | -46.9% | -351.6% | -849.2% | -812.4% | -325.2% | -268.8% | -285.4% | -60.5% | -126.0% | -231.4% | 48.8% | 65.6% | -2,851.6% | -2,781.3% | -70,913.8% | -130,666.7% | -167,476.9% | 58.9% | -170.2% | – | -117.0% | |
| – | -559.8% | -603.7% | -360.9% | -334.4% | -561.4% | -339.0% | -397.6% | -293.0% | -358.8% | -2,805.9% | -319.4% | -237.2% | -99.2% | 35.4% | -36.0% | -311.5% | -779.9% | -749.5% | -177.1% | -157.3% | -127.0% | -0.5% | -72.4% | -160.5% | 60.2% | 69.5% | -2,631.6% | -2,601.3% | -67,262.1% | -124,811.1% | -159,507.7% | 59.3% | -161.4% | – | -111.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.